Hepatitis Treatment News
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis Treatment News


July 27, 2015
In Those With HIV, Best to Treat Hep B With Two Drugs
Among HIV-positive people, it is preferable to treat hepatitis B with a two-drug regimen rather than with monotherapy.
July 24, 2015
FDA OK’s BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3
The FDA has approved BMS's Daklinza (daclatasvir) to be used with Gilead Sciences’ Sovaldi (sofosbuvir) to treat genotype 3 of hepatitis C.
FDA Green Lights AbbVie’s Technivie for Genotype 4 of Hepatitis C
The FDA has approved AbbVie’s single-tablet combination regimen Technivie plus ribavirin to treat genotype 4 of hepatitis C virus among those without cirrhosis.
July 21, 2015
Liver Association Updates Hepatitis C Treatment Guidelines
The American Association for the Study of Liver Diseases has updated the treatment guidelines for hepatitis C.
July 15, 2015
The CDC’s Surveillance of Acute Hepatitis C Cases Is Poor
The Centers for Disease Control and Prevention’s (CDC) monitoring of acute, or very early, hepatitis C virus (HCV) cases is woefully inadequate.
July 13, 2015
NASH May Affect Metabolism of Type-2 Diabetes Drug
People with type-2 diabetes who take metformin may have an altered ability to metabolize the drug if they also have nonalcoholic steatohepatitis (NASH)
July 08, 2015
Hepatitis C Has Large Impact in Sub-Saharan Africa
Sub-Saharan Africa has a high prevalence of hepatitis C, especially among HIV-positive individuals.
July 06, 2015
Hep C Coinfection Increases Death Risk in Drug Users With HIV
The raised risk of death resulting from injection drug use among people with HIV is substantially explained by hep C coinfection among that population.
July 01, 2015
Viekira Pak Cures Hep C in 100% of Cirrhotic Genotype 1bs
AbbVie’s Viekira Pak cured all people with genotype 1b of hepatitis C and compensated cirrhosis in a recent late-stage trial.
Archives
   

July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
January 2008


QUICK LINKS

Current Issue
Forums
Poll
Blogs
Hep Stories
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
TALK TO US
Tell us what you think
Poll
Are you a baby boomer (born between 1945 and 1965)?
Yes
No


Survey
Hepatitis C Reader Survey
HEP ON TWITTER
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.